Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
1975-5-27
|
| pubmed:language |
pol
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1427-941X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
19
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
119-46
|
| pubmed:dateRevised |
2007-8-29
|
| pubmed:meshHeading |
pubmed-meshheading:4217934-Chromosome Aberrations,
pubmed-meshheading:4217934-Chromosomes,
pubmed-meshheading:4217934-Humans,
pubmed-meshheading:4217934-Melphalan,
pubmed-meshheading:4217934-Methotrexate,
pubmed-meshheading:4217934-Mutation,
pubmed-meshheading:4217934-Sulfates,
pubmed-meshheading:4217934-Time Factors,
pubmed-meshheading:4217934-Vinblastine
|
| pubmed:year |
1974
|
| pubmed:articleTitle |
[In vitro effects of vinblastine sulfate, methotrexate and alkeran on human chromosomes].
|
| pubmed:publicationType |
Journal Article,
English Abstract
|